Ⓐ
PeptiBrief
Research peptide

Sermorelin

Sermorelin is a research peptide indexed in the PeptiBrief evidence database.

Evidence confidence

Human
Not yet assessed
Trust Engine review pending.
Animal
Not yet assessed
Trust Engine review pending.
Mechanistic
Not yet assessed
Trust Engine review pending — see editorial links below.
Editorial evidence links exist, but this category has not yet completed Trust Engine assessment.
Safety
Not yet assessed
Trust Engine review pending.

Claimed uses

Mechanisms

Safety notes

Long-term safety, validated dosing and product quality may be uncertain outside formal clinical development.

Regulation
  • Historically approved in the United States for selected paediatric uses and later discontinued commercially; compounded availability does not equal current regulatory approval for anti-ageing or performance use.
  • Not approved for general wellness or performance use unless a specific regulated product and indication exists.

References

  1. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency · 1999
Last reviewed
12 July 2026
Important PeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.